SILVER SPRING
mFLUSIVA cleared for seasonal influenza in adults
- Sponsor
- Moderna $MRNA
- Drug
- mFLUSIVA · mRNA-1010
- Indication
- Prevention of seasonal influenza
FDA approves Moderna's mRNA influenza vaccine mFLUSIVA for the prevention of seasonal influenza in adults.
What this means
mFLUSIVA is a vaccine that uses messenger RNA to instruct the body's cells to make proteins found in flu viruses, training the immune system to fight off infection. The FDA has cleared it for the prevention of seasonal influenza in adults. This provides a new, mRNA-based option alongside traditional flu shots for annual vaccination.